Swiss Primary Sclerosing Cholangitis Cohort Study

Fondazione Epatocentro Ticino

Status: Enrolling

Conditions: Primary Sclerosing Cholangitis (PSC); PSC; Cholangitis, Sclerosing

Study type: Observational

Funder types: Other

Identifiers

NCT03146936

SASL40 - Swiss PSC Cohort

Details and patient eligibility

About

Research project in which biological material is sampled and health-related personal data is further used and collected.

Coded data are used.

Full description

The investigators wish to collect high quality prospective data on a rare disease in order to elucidate epidemiology, natural history, response to treatment and outcome. In addition, a biobank allows addressing specific scientific issues on a variety of open questions. The cohort will provide a platform for carrying out scientific research projects on PSC. In addition, the cohort will allow collaborations with reference networks on PSC abroad

Enrollment: 120 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with PSC according to established criteria (European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases) of any age. Patients not fulfilling such criteria but still diagnosed with PSC in a hepatology referral centre can be included
• patients living in Switzerland

Exclusion criteria

• N/A